Dr Suzanne Rogers
Senior Research Fellow
| telephone | +61 3 9288 2582 |
| facsmilie | +61 3 9288 2581 |
| sdrogers @ unimelb.edu.au |
Profile
Dr Suzanne Rogers is a Senior Research Fellow and research group leader. Her research group includes scientists and postgraduate students studying the molecular and cellular biology of mammalian glucose transporter (GLUT) proteins, their role in glucose homeostasis and disease, with particular emphasis on type 2 diabetes and cancer.
University of Melbourne find an expert profile
Professional Activities:
Honours Convener. Design of research projects and funding applications. Primary supervision of staff and students. Communication of research results in peer reviewed journals and presentation at international and national scientific conferences. Honorary Fellow of St Vincent's Institute.
Qualifications
BSc (Hons) PhD
Major Grants
- Linking diet to diabetes (MBF Foundation 2008)
- Mechanisms that link type 2 diabetes to increased cancer risk (Diabetes Australia Research Trust 2007)
- Linking diabetes to an increased risk of breast and prostate cancer (Cancer and Bowel Research Trust 2008)
- Cellular mechanisms and physiological roles of GLUT12 mediated glucose transport in glucose homeostasis. (NHMRC Project Grant, 2005-2007, $491,500) S Rogers, J Best, J Proietto, J Favaloro.
- Targeting the novel glucose transporter GLUT 12 for the early detection of breast cancer. (Friends for an Earlier Breast Cancer Test Grant, 2006, USD 8,250) S Rogers.
Selected Publications
- Wilson-O'Brien AL, DeHaan CL and Rogers S.
Mitogen activated and rapamycin sensitive targeting of GLUT12 in renal epithelial cells.
Endocrinology, 149:917-924, 2008. CI: 1; IF: 5.045
- Linden KC, DeHaan CL, Zhang Y, Glowacka S, Cox AJ, Kelly DJ and Rogers S. Renal expression and localization of the facilitative glucose transporters GLUT1 and GLUT12 in animal models of hypertension and diabetic nephropathy. Am J Physiol Renal Physiol. Jan 290(1): F205-F213, 2006. CI:4; IF: 4.256
- M Macheda, S Rogers and J Best. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 202(3): 654-62, 2005. CI: 37; IF: 4.362
- Chandler JD, Williams ED, Slavin JL, Best JD, Rogers S.Expression and localisation of GLUT1 and GLUT12 in prostate cancer. Cancer 97: 2035-2042, 2003. CI: 26; IF: 4.800
- Rogers S, Docherty SE, Slavin JL, Henderson MA, Best JD. Differential expression of GLUT12 in breast cancer and normal breast tissue. Cancer Letters 193: 225-233, 2003. CI: 14; IF: 3.049
- Rogers, SD, Macheda, ML, Docherty, SE, Carty, MD, Henderson, MA, Soeller, WC, Gibbs, EM, James, DE, Best, JD. Identification of a novel glucose transporter-like protein - GLUT 12. Am. J. Physiol. Endocrinology and Metabolism 282 (3): E733-E738, 2002. CI: 46; IF: 4.456
- Joost HG, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, Moley JF, Mueckler M, Rogers S, Schurmann A, Seino S, Thorens B. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am. J. Physiol. Endocrinol. Metab. 282(4): E974-6, 2002. CI: 81; IF: 4.456